
Innovation has to solve more than a technical problem
Ultrasound has a distinctive position in modern healthcare. It can provide real-time imaging without ionising radiation, can be used across a wide range of clinical applications and, in many settings, can be deployed with considerably less infrastructure than larger imaging modalities.
Yet the global challenge is not simply how to make ultrasound technology more advanced. It is how to make advanced imaging more accessible, more usable, more adaptable and more clinically valuable across very different healthcare environments.
That changes the question facing ultrasound innovators.
The challenge is no longer only: “How can we produce a better image?”
It is increasingly: “How can we develop imaging technology that works for the patient, clinician and healthcare system in which it will actually be used?”
Access remains one of healthcare's fundamental challenges
The global demand for diagnostic imaging continues to grow, but access is not evenly distributed.
The World Health Organization has highlighted significant inequalities in access to medical imaging, particularly in developing countries and remote and underserved areas. Access depends not only on the availability of equipment, but also on infrastructure, operating costs, maintenance and appropriately trained healthcare professionals.
This creates an important distinction between technological availability and clinical accessibility.
A sophisticated imaging system may exist somewhere in the world, but that does not mean that the technology is accessible to every patient who could benefit from it.
For ultrasound innovators, this raises a broader design consideration: technology needs to be developed with the realities of different healthcare systems in mind.
Portability, reliability, ease of use, serviceability, integration and cost can be just as important as image resolution.
The paradox of increasingly sophisticated ultrasound
At the same time that healthcare systems need accessible imaging, clinical applications are becoming increasingly sophisticated.
Ultrasound is moving beyond conventional diagnostic imaging into interventional cardiology, surgery, critical care and other image-guided procedures.
The technology required for these applications can be considerably more demanding.
A transducer may need to be smaller while maintaining image quality. It may need to operate within a catheter or other constrained access route. It may need sophisticated steering capabilities. And it may need to deliver two-dimensional or three-dimensional information in real time.
This is where miniaturisation becomes more than an engineering exercise, as it becomes an enabler of new clinical possibilities.
Oldelft Ultrasound has specialised in ultrasound transducer development since the 1980s and introduced its first transoesophageal echocardiography (TEE) transducers in 1988. Today, its portfolio includes miniaturised 2D and 4D ultrasound technologies, including catheter-based 4D imaging.
Its 4D ICE transducer, for example, is designed to fit within a 12 French catheter and incorporates a 1,024-element acoustic array.
The underlying challenge is significant: achieving the imaging performance required for increasingly complex procedures while working within increasingly constrained physical dimensions.
The workforce challenge
Advanced equipment does not automatically create better healthcare.
Healthcare professionals need the training, experience and confidence to use it effectively.
This is particularly relevant as ultrasound moves into point-of-care and increasingly specialised applications.
Recent international research into AI-assisted point-of-care ultrasound found that healthcare professionals identified training and education as the most frequently cited single barrier to implementation, followed by clinical validation and evidence. The study surveyed 1,154 healthcare professionals.
This highlights an important principle for innovation: Technology adoption is partly a human-factors problem.
A device can be technically impressive and still fail to achieve its potential if it does not fit clinical workflows, if users cannot be adequately trained, or if there is insufficient evidence to support its application.
For ultrasound manufacturers and technology developers, usability therefore needs to be considered alongside technical performance from the beginning of the development process.
AI brings opportunity and another layer of complexity
Artificial intelligence is becoming an increasingly important part of the ultrasound conversation. AI is being explored for image acquisition, image interpretation, education, procedural guidance, automation and quality assurance. The potential is considerable.
AI could potentially assist less experienced users with image acquisition, help standardise measurements, identify relevant structures or support interpretation.
But AI also introduces new challenges.
Researchers have identified concerns around population bias, explainability, clinical effectiveness, workflow integration and trust. A 2025 review of AI in point-of-care ultrasound specifically highlighted the importance of representative training data and clinically meaningful validation.
More recent research similarly identifies limited outcomes-based evidence, dataset bias, workflow integration and regulatory uncertainty as barriers to adoption.
The lesson is important.
Adding AI to ultrasound does not remove the need for clinical expertise. In many applications, it increases the importance of understanding how technology performs in real-world clinical environments.
Innovation must work across healthcare environments
A technology developed for a major specialist hospital in Europe may face very different requirements when considered for a regional hospital, mobile diagnostic service or healthcare facility in a resource-constrained environment.
That does not mean developing entirely different technologies for every market.
It means designing platforms and components with adaptability in mind.
For ultrasound, this can include:
The WHO's work on strengthening medical imaging capacity reflects this broader systems perspective: equipment is only one part of the infrastructure required to deliver effective diagnostic imaging.
The challenge of making advanced imaging smaller
One of the most interesting directions in ultrasound innovation is the continued reduction in the physical size of transducers without compromising their clinical capabilities. This is particularly important for minimally invasive procedures.
Smaller transducers can potentially bring imaging closer to the anatomy being treated, creating opportunities for real-time procedural guidance.
But miniaturisation creates a series of interconnected engineering challenges.
Reducing the physical footprint can affect acoustic performance, thermal management, electronics, mechanical steering and ergonomics.
Oldelft's recent work on miniaturised 4D TEE probes illustrates the complexity. The company identifies thermal management, acoustic performance within a micro-footprint and precise multi-directional manoeuvrability as three key engineering challenges when reducing probe size.
The objective is therefore not simply to make a probe smaller. It is to preserve, or improve its clinical functionality while making it small enough to support procedures that were previously difficult or impossible to image in the same way.
From products to partnerships
Another challenge in medical imaging innovation is that no single company necessarily controls the entire technology stack.
An ultrasound transducer is one component within a much larger ecosystem that can include electronics, imaging platforms, software, AI, navigation systems, catheters, surgical instruments and clinical workflows. This makes collaboration increasingly important.
Oldelft's business model reflects this reality. The company works with ultrasound OEMs and develops tailor-made transducer solutions, drawing on expertise in ASIC development, acoustics, 4D imaging and miniaturisation. Its stated applications include cardiology, surgery and urology.
For medical technology companies developing new imaging applications, specialist transducer expertise can therefore become part of the innovation strategy rather than simply a component-sourcing decision.
Innovation must also be clinically meaningful
There is an understandable tendency in technology development to focus on what can be engineered.
But healthcare ultimately asks a different question: What does the technology enable clinicians to do?
That distinction matters.
Higher resolution is valuable when it enables better visualisation.
Miniaturisation is valuable when it enables access to anatomy that could not previously be imaged in the same way.
4D imaging is valuable when three-dimensional, real-time information changes clinical understanding or procedural guidance.
AI is valuable when it improves acquisition, interpretation, consistency or workflow without creating unacceptable new risks.
The measure of innovation therefore cannot simply be technical novelty. It has to include clinical utility.
The next challenge: integrating the technologies
The future of ultrasound is unlikely to be defined by a single breakthrough. Instead, progress will increasingly come from the integration of multiple technologies.
Each technology addresses part of the challenge.
Together, they have the potential to change how imaging is incorporated into clinical care.
“Oldelft Ultrasound's participation in the €23.5 million, five-year SEISMICIHI research programme illustrates this direction. The consortium is developing technologies that combine minimally invasive treatment with advanced imaging, with Oldelft Ultrasound responsible for developing a 4D ultrasound probe designed to visualise the brain during cryoablation of brain tumours. The programme includes eight clinical studies.
This is an example of an important shift in medical imaging. The question is no longer simply how to create an image. It is how to place the right imaging capability at the right point in the clinical workflow.” says Michiel Baas, R&D Manager at Oldelft Ultrasound, in Delft The Netherlands.
Designing for the healthcare system of tomorrow
Global healthcare challenges will not be solved by technology alone. They require clinicians, medical device manufacturers, engineers, researchers, regulators and healthcare systems to work together.
For ultrasound, that means innovation must address several requirements simultaneously:
The most useful innovation will be the innovation that recognises all of these requirements rather than optimising for only one.
The future of ultrasound is not simply smaller, smarter or more powerful
It is more connected to the realities of healthcare.
“As ultrasound moves further into minimally invasive intervention, point-of-care diagnostics and advanced image-guided procedures, transducer technology becomes increasingly important to what clinicians can see, and ultimately, what they can do.
For Oldelft Ultrasound, that means continuing to push the boundaries of miniaturised 2D and 4D transducer technology while working closely with medical technology partners to translate engineering capability into clinical applications. Oldelft Ultrasound's integration into the steute Technologies Group in 2026 adds another dimension to this approach, bringing its ultrasound expertise together with steute's established medical technology capabilities.
The global healthcare challenge is therefore not simply to invent the next ultrasound technology. It is to make advanced imaging useful where it matters most: in the hands of healthcare professionals, within real clinical workflows, and ultimately in the service of patients. That is where meaningful ultrasound innovation begins.” says Erwin Dumay, Managing Director at Oldelft Ultrasound.
About Oldelft Ultrasound
Oldelft Ultrasound is a medical diagnostic company, specialized in the development, manufacture and service of innovative Ultrasound transducers. Oldelft Ultrasound is an OEM supplier to the Ultrasound equipment companies worldwide. Oldelft Ultrasound is especially well-known for its TEE (Trans Esophageal Echocardiography) transducers, and specialists in miniaturization of transducers. Based out of Delft, in The Netherlands, Oldelft Ultrasound is part of the steute Technologies group.
Oldelft Ultrasound - Commercial Contact - Stefan Roggeveen - info@oldelft.nl